Investors & Media

Investor Kit

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kamada Announces Strategic Transformational Transaction Positioning the Company as a Global Leader in the Plasma-Derived Hyperimmune Market Through the Acquisition of a Portfolio of Four FDA-Approved Commercial Products
Nov. 22, 2021